Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001144204-12-064460
Filing Date
2012-11-21
Accepted
2012-11-21 14:15:45
Documents
1
Group Members
ARTHUR COHENHEALTHCOR ASSOCIATES, LLCHEALTHCOR GROUP, LLCHEALTHCOR HYBRID OFFSHORE GP, LLCHEALTHCOR HYBRID OFFSHORE MASTER FUND, L.P.HEALTHCOR LONG MASTER GP, LLCHEALTHCOR LONG OFFSHORE MASTER FUND, L.P.HEALTHCOR OFFSHORE GP, LLCHEALTHCOR OFFSHORE MASTER

Document Format Files

Seq Description Document Type Size
1 SC 13G v781130_sc13g.txt SC 13G 41897
  Complete submission text file 0001144204-12-064460.txt   43839
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Subject) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-80035 | Film No.: 121220825
SIC: 2834 Pharmaceutical Preparations

Mailing Address 152 WEST 57TH STREET 43RD FLOOR NEW YORK NY 10019
Business Address 152 WEST 57TH STREET 43RD FLOOR NEW YORK NY 10019 212-622-7871
HealthCor Management, L.P. (Filed by) CIK: 0001343781 (see all company filings)

EIN.: 202893581 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G